245 related articles for article (PubMed ID: 31211399)
1. Comparison of disease activity measures in early psoriatic arthritis in usual care.
Wervers K; Luime JJ; Tchetverikov I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Vis M;
Rheumatology (Oxford); 2019 Dec; 58(12):2251-2259. PubMed ID: 31211399
[TBL] [Abstract][Full Text] [Related]
2. Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study.
Tillett W; FitzGerald O; Coates LC; Packham J; Jadon DR; Massarotti M; Brook M; Lane S; Creamer P; Antony A; Korendowych E; Rambojun A; McHugh NJ; Helliwell PS;
J Rheumatol Suppl; 2021 Jun; 97():39-44. PubMed ID: 34074665
[TBL] [Abstract][Full Text] [Related]
3. Need for Improvement in Current Treatment of Psoriatic Arthritis: Study of an Outpatient Clinic Population.
Michelsen B; Diamantopoulos AP; Høiberg HK; Soldal DM; Kavanaugh A; Haugeberg G
J Rheumatol; 2017 Apr; 44(4):431-436. PubMed ID: 28148701
[TBL] [Abstract][Full Text] [Related]
4. Composite Measures for Clinical Trials in Psoriatic Arthritis: Testing Pain and Fatigue Modifications in a UK Multicenter Study.
Tillett W; FitzGerald O; Coates LC; Packham J; Jadon DR; Massarotti M; Brook M; Lane S; Creamer P; Antony A; Korendowych E; Rambojun A; McHugh NJ; Helliwell PS;
J Rheumatol; 2021 Mar; ():. PubMed ID: 33649073
[TBL] [Abstract][Full Text] [Related]
5. Disease-specific composite measures for psoriatic arthritis are highly responsive to a Janus kinase inhibitor treatment that targets multiple domains of disease.
Helliwell P; Coates LC; FitzGerald O; Nash P; Soriano ER; Elaine Husni M; Hsu MA; Kanik KS; Hendrikx T; Wu J; Kudlacz E
Arthritis Res Ther; 2018 Oct; 20(1):242. PubMed ID: 30373651
[TBL] [Abstract][Full Text] [Related]
6. Evaluation and Validation of a Patient-completed Psoriatic Arthritis Flare Questionnaire.
Helliwell PS; Tillett W; Waxman R; Coates LC; Brooke M; FitzGerald O; Packham JC; McHugh N;
J Rheumatol; 2021 Aug; 48(8):1268-1271. PubMed ID: 33589558
[TBL] [Abstract][Full Text] [Related]
7. Comparison of Composite Indices Tailored for Psoriatic Arthritis Treated with csDMARD and bDMARD: A Cross-sectional Analysis of a Longitudinal Cohort.
Lubrano E; De Socio A; Perrotta FM
J Rheumatol; 2017 Aug; 44(8):1159-1164. PubMed ID: 28572467
[TBL] [Abstract][Full Text] [Related]
8. Defining Low Disease Activity States in Psoriatic Arthritis using Novel Composite Disease Instruments.
Coates LC; Helliwell PS
J Rheumatol; 2016 Feb; 43(2):371-5. PubMed ID: 26669918
[TBL] [Abstract][Full Text] [Related]
9. Composite Measures for Routine Clinical Practice in Psoriatic Arthritis: Testing of Shortened Versions in a UK Multicenter Study.
Tillett W; FitzGerald O; Coates LC; Packham J; Jadon DR; Massarotti M; Brook M; Lane S; Creamer P; Antony A; Korendowych E; Rambojun A; McHugh NJ; Helliwell PS;
J Rheumatol Suppl; 2021 Jun; 97():45-49. PubMed ID: 34074666
[TBL] [Abstract][Full Text] [Related]
10. Ultrasonographic evaluation in psoriatic arthritis is of major importance in evaluating disease activity.
Michelsen B; Diamantopoulos AP; Hammer HB; Soldal DM; Kavanaugh A; Haugeberg G
Ann Rheum Dis; 2016 Dec; 75(12):2108-2113. PubMed ID: 27091837
[TBL] [Abstract][Full Text] [Related]
11. Disease activity in psoriatic arthritis: comparison of the discriminative capacity and construct validity of six composite indices in a real world.
Salaffi F; Ciapetti A; Carotti M; Gasparini S; Gutierrez M
Biomed Res Int; 2014; 2014():528105. PubMed ID: 24967375
[TBL] [Abstract][Full Text] [Related]
12. The relationship between patient acceptable symptom state and disease activity in patients with psoriatic arthritis.
Fei JZ; Perruccio AV; Ye JY; Gladman DD; Chandran V
Rheumatology (Oxford); 2020 Jan; 59(1):69-76. PubMed ID: 31199486
[TBL] [Abstract][Full Text] [Related]
13. The development of candidate composite disease activity and responder indices for psoriatic arthritis (GRACE project).
Helliwell PS; FitzGerald O; Fransen J; Gladman DD; Kreuger GG; Callis-Duffin K; McHugh N; Mease PJ; Strand V; Waxman R; Azevedo VF; Beltran Ostos A; Carneiro S; Cauli A; Espinoza LR; Flynn JA; Hassan N; Healy P; Kerzberg EM; Lee YJ; Lubrano E; Marchesoni A; Marzo-Ortega H; Porru G; Moreta EG; Nash P; Raffayova H; Ranza R; Raychaudhuri SP; Roussou E; Scarpa R; Song YW; Soriano ER; Tak PP; Ujfalussy I; de Vlam K; Walsh JA
Ann Rheum Dis; 2013 Jun; 72(6):986-91. PubMed ID: 22798567
[TBL] [Abstract][Full Text] [Related]
14. Composite Measures of Disease Activity in Psoriatic Arthritis: Comparative Instrument Performance Based on the Efficacy of Guselkumab in an Interventional Phase II Trial.
Helliwell PS; Deodhar A; Gottlieb AB; Boehncke WH; Xu XL; Xu S; Wang Y; Hsia EC; Gladman DD; Ritchlin CT
Arthritis Care Res (Hoboken); 2020 Nov; 72(11):1579-1588. PubMed ID: 31421033
[TBL] [Abstract][Full Text] [Related]
15. Comparison of composite measures of disease activity in psoriatic arthritis using data from an interventional study with golimumab.
Helliwell PS; Kavanaugh A
Arthritis Care Res (Hoboken); 2014 May; 66(5):749-56. PubMed ID: 24127416
[TBL] [Abstract][Full Text] [Related]
16. Construct validity and responsiveness of feasible composite disease activity measures for use in daily clinical practice in patients with psoriatic arthritis.
Kasiem FR; Kok MR; Luime JJ; Tchetverikov I; Korswagen LA; Denissen NHAM; Goekoop-Ruiterman YPM; van Oosterhout M; Fodili F; Hazes JMW; Tillett W; Vis M;
RMD Open; 2023 Oct; 9(4):. PubMed ID: 37880177
[TBL] [Abstract][Full Text] [Related]
17. Burden of Psoriatic Arthritis According to Different Definitions of Disease Activity: Comparing Minimal Disease Activity and the Disease Activity Index for Psoriatic Arthritis.
Wervers K; Vis M; Tchetveriko I; Gerards AH; Kok MR; Appels CWY; van der Graaff WL; van Groenendael JHLM; Korswagen LA; Veris-van Dieren JJ; Hazes JMW; Luime JJ
Arthritis Care Res (Hoboken); 2018 Dec; 70(12):1764-1770. PubMed ID: 29609220
[TBL] [Abstract][Full Text] [Related]
18. Value of the Routine Assessment of Patient Index Data 3 in Patients With Psoriatic Arthritis: Results From a Tight-Control Clinical Trial and an Observational Cohort.
Coates LC; Tillett W; Shaddick G; Pincus T; Kavanaugh A; Helliwell PS
Arthritis Care Res (Hoboken); 2018 Aug; 70(8):1198-1205. PubMed ID: 29112801
[TBL] [Abstract][Full Text] [Related]
19. Composite disease activity and responder indices for psoriatic arthritis: a report from the GRAPPA 2013 meeting on development of cutoffs for both disease activity states and response.
Helliwell PS; FitzGerald O; Fransen J
J Rheumatol; 2014 Jun; 41(6):1212-7. PubMed ID: 24882854
[TBL] [Abstract][Full Text] [Related]
20. Evaluating current definitions of low disease activity in psoriatic arthritis using ultrasound.
Bosch P; Husic R; Ficjan A; Gretler J; Lackner A; Graninger WB; Duftner C; Hermann J; Dejaco C
Rheumatology (Oxford); 2019 Dec; 58(12):2212-2220. PubMed ID: 31199483
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
